Cargando…

Identification of Six N7-Methylguanosine-Related miRNA Signatures to Predict the Overall Survival and Immune Landscape of Triple-Negative Breast Cancer through In Silico Analysis

Triple-negative breast cancer (TNBC) is a widely prevalent breast cancer, with a mortality rate of up to 25%. TNBC has a lower survival rate, and the significance of N7-methylguanosine (m7G) modification in TNBC remains unclear. Thus, this study is aimed at investigating m7G-related miRNAs in TNBC p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jing, Cen, Xiaoxia, Yao, Yu, Zhao, Suo, Li, Wei, Zhang, Wei, Qiu, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529398/ https://www.ncbi.nlm.nih.gov/pubmed/36199792 http://dx.doi.org/10.1155/2022/2735251

Ejemplares similares

N7-methylguanosine-related miRNAs predict hepatocellular carcinoma prognosis and immune therapy
por: Ma, Liping, et al.
Publicado: (2023)

Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma
por: Wei, Wei, et al.
Publicado: (2022)

A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma
por: Duan, Han-ping, et al.
Publicado: (2023)

A Novel 7-Methylguanosine (m7G)-Related Gene Signature for Overall Survival Prediction in Patient with Clear Cell Renal Cell Carcinoma
por: Fu, Yongxin, et al.
Publicado: (2023)

Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer
por: Thakur, Seema, et al.
Publicado: (2016)

Large miRNA survival analysis reveals a prognostic four-biomarker signature for triple negative breast cancer
por: Andrade, Fernando, et al.
Publicado: (2020)

Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma
por: Li, Zhouhua, et al.
Publicado: (2022)

Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
por: Liu, Gao-Min, et al.
Publicado: (2019)

A Six-Epithelial–Mesenchymal Transition Gene Signature May Predict Metastasis of Triple-Negative Breast Cancer
por: Wei, Li Yuan, et al.
Publicado: (2020)

Characterization of the mammalian miRNA turnover landscape
por: Guo, Yanwen, et al.
Publicado: (2015)

Detection of miRNA regulatory effect on triple negative breast cancer transcriptome
por: Martignetti, Loredana, et al.
Publicado: (2015)

miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
por: Mathe, Andrea, et al.
Publicado: (2015)

Circulating cell-free miRNAs as biomarker for triple-negative breast cancer
por: Shin, V Y, et al.
Publicado: (2015)

The role of melatonin on miRNAs modulation in triple-negative breast cancer cells
por: Ferreira, Lívia C., et al.
Publicado: (2020)

Expression pattern, tumor immune landscape, and prognostic value of N7‑methylguanosine regulators in bladder urothelial carcinoma
por: Zhang, Chi, et al.
Publicado: (2023)

Landscape of internal N7-methylguanosine of long non-coding RNA modifications in resistant acute myeloid leukemia
por: Han, Jingyi, et al.
Publicado: (2023)

Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures
por: Lu, Fei, et al.
Publicado: (2022)

Construction and Validation of a Novel Prognostic Signature of Idiopathic Pulmonary Fibrosis by Identifying Subtypes Based on Genes Related to 7-Methylguanosine Modification
por: Huang, Tao, et al.
Publicado: (2022)

Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer
por: Huang, Yuan, et al.
Publicado: (2021)

7-Methylguanosine Modifications in Transfer RNA (tRNA)
por: Tomikawa, Chie
Publicado: (2018)

Development of a Novel Six-miRNA-Based Model to Predict Overall Survival Among Colon Adenocarcinoma Patients
por: Rong, Zhenxiang, et al.
Publicado: (2020)

Identification of N(7)-methylguanosine-related IncRNA signature as a potential predictive biomarker for colon adenocarcinoma
por: Ma, Xiaomei, et al.
Publicado: (2022)

A potential biological signature of 7-methylguanosine-related lncRNA to predict the immunotherapy effects in bladder cancer
por: Xie, Shangxun, et al.
Publicado: (2023)

The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer
por: Adinew, Getinet M., et al.
Publicado: (2021)

LncRNA PART1 Promotes Proliferation and Migration, Is Associated with Cancer Stem Cells, and Alters the miRNA Landscape in Triple-Negative Breast Cancer
por: Cruickshank, Brianne M., et al.
Publicado: (2021)

Inhibition of miRNA-34a promotes triple negative cancer cell proliferation by promoting glucose uptake
por: Li, Zhen, et al.
Publicado: (2019)

A Novel Risk-Score Model With Eight MiRNA Signatures for Overall Survival of Patients With Lung Adenocarcinoma
por: Wu, Jun, et al.
Publicado: (2021)

Increased expression of six-large extracellular vesicle-derived miRNAs signature for nonvalvular atrial fibrillation
por: Siwaponanan, Panjaree, et al.
Publicado: (2022)

Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers
por: Verderio, P, et al.
Publicado: (2016)

An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer
por: Ren, Lei, et al.
Publicado: (2023)

Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
por: Duttagupta, Radha, et al.
Publicado: (2011)

A novel prognostic signature based on N7-methylguanosine-related long non-coding RNAs in breast cancer
por: Huang, Zhidong, et al.
Publicado: (2022)

Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response
por: Cao, Jin, et al.
Publicado: (2022)

Establishment and validation of an individualized macrophage-related gene signature to predict overall survival in patients with triple negative breast cancer
por: Su, Peng, et al.
Publicado: (2021)

Response to: Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'
por: Shin, Vivian Y, et al.
Publicado: (2016)

MiRNAs Predict the Prognosis of Patients with Triple Negative Breast Cancer: A Meta-Analysis
por: Liu, Yanli, et al.
Publicado: (2017)

MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review
por: Volovat, Simona Ruxandra, et al.
Publicado: (2020)

Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer
por: Wu, Jiande, et al.
Publicado: (2020)

The landscape of miRNA editing in animals and its impact on miRNA biogenesis and targeting
por: Li, Lishi, et al.
Publicado: (2018)

Ssa miRNAs DB: Online repository of in silico predicted miRNAs in Salmo salar
por: Reyes, Daniela, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_b6ml9bsoho82vakeb0qel0nn3s